{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:58:17Z","timestamp":1791302297076,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010481","name":"Etablissement Fran\u00e7ais du Sang","doi-asserted-by":"crossref","award":["#2013-03-Douay-IDF"],"award-info":[{"award-number":["#2013-03-Douay-IDF"]}],"id":[{"id":"10.13039\/501100010481","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijpharm.2016.09.081","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T02:13:42Z","timestamp":1475633622000},"page":"678-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Targeted release of transcription factors for cell reprogramming by a natural micro-syringe"],"prefix":"10.1016","volume":"513","author":[{"given":"Lionel","family":"Berthoin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Garban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Le Gouellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Caulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-6249","authenticated-orcid":false,"given":"Beno\u00eet","family":"Polack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Laurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.09.081_bib0005","doi-asserted-by":"crossref","first-page":"23387","DOI":"10.1074\/jbc.M000932200","article-title":"Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer","volume":"275","author":"Ambrosetti","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1566523211313020002","article-title":"Technological overview of iPS induction from human adult somatic cells","volume":"13","author":"Bayart","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/cell.2012.0058","article-title":"Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein","volume":"15","author":"Bichsel","year":"2013","journal-title":"Cell. Reprogramming"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0020","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","article-title":"Core transcriptional regulatory circuitry in human embryonic stem cells","volume":"122","author":"Boyer","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0025","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","article-title":"Core transcriptional regulatory circuitry in human embryonic stem cells","volume":"122","author":"Boyer","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood-2010-02-269589","article-title":"Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation","volume":"116","author":"Cho","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0035","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/mrd.22263","article-title":"Activation of pluripotency genes by a nanotube-mediated protein delivery system","volume":"80","author":"Cho","year":"2013","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/bbug.1.1.9482","article-title":"Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2","volume":"1","author":"Derouazi","year":"2010","journal-title":"Bioeng. Bugs"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0045","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ymthe.2006.06.011","article-title":"Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector","volume":"14","author":"Epaulard","year":"2006","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tcb.2013.09.011","article-title":"The use of small molecules in somatic-cell reprogramming","volume":"24","author":"Federation","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/cr.2013.165","article-title":"Regenerative medicine: transdifferentiation in vivo","volume":"24","author":"Fu","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-micro-092412-155725","article-title":"Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells","volume":"68","author":"Gal\u00e1n","year":"2014","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nbt1418","article-title":"Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds","volume":"26","author":"Huangfu","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2004.10.018","article-title":"Cationic TAT peptide transduction domain enters cells by macropinocytosis","volume":"102","author":"Kaplan","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0075","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.biomaterials.2013.03.072","article-title":"Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector","volume":"34","author":"Khan","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.cell.2008.02.039","article-title":"An extended transcriptional network for pluripotency of embryonic stem cells","volume":"132","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","article-title":"Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins","volume":"4","author":"Kim","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020185","article-title":"Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos","volume":"17","author":"Kristensen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0095","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1372131","article-title":"Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice","volume":"255","author":"Lapidot","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0100","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/mt.2013.41","article-title":"A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy","volume":"21","author":"Le Gou\u00ebllec","year":"2013","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0105","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cell.2012.09.034","article-title":"Activation of innate immunity is required for efficient nuclear reprogramming","volume":"151","author":"Lee","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0110","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jconrel.2016.02.002","article-title":"Emerging landscape of cell penetrating peptide in reprogramming and gene editing","volume":"226","author":"Liu","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0120","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ymthe.2004.08.010","article-title":"Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement","volume":"10","author":"Nakase","year":"2004","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/ten.tec.2013.0026","article-title":"Generation of mouse induced pluripotent stem cells by protein transduction","volume":"20","author":"Nemes","year":"2014","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","article-title":"Generation of germline-competent induced pluripotent stem cells","volume":"448","author":"Okita","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5966\/sctm.2013-0149","article-title":"Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategies","volume":"3","author":"Park","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5966\/sctm.2013-0149","article-title":"Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategies","volume":"3","author":"Park","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0145","doi-asserted-by":"crossref","first-page":"24731","DOI":"10.1074\/jbc.M502573200","article-title":"Transcriptional regulation of nanog by OCT4 and SOX2","volume":"280","author":"Rodda","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0150","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.scr.2016.03.008","article-title":"Generation of human induced pluripotent stem cells using non-synthetic mRNA","volume":"16","author":"Rohani","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tcb.2015.08.006","article-title":"Nuclear reprogramming by defined factors: quantity versus quality","volume":"26","author":"Sebban","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0160","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.4161\/cc.24663","article-title":"Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome","volume":"12","author":"Soufi","year":"2013","journal-title":"Cell Cycle (Georgetown Texas)"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0165","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/nprot.2007.418","article-title":"Induction of pluripotent stem cells from fibroblast cultures","volume":"2","author":"Takahashi","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0170","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0175","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1073\/pnas.0504405102","article-title":"A secreted regulatory protein couples transcription to the secretory activity of the Pseudomonas aeruginosa type III secretion system","volume":"102","author":"Urbanowski","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0180","first-page":"223","article-title":"Optimization of antitumor immunotherapy mediated by type III secretion system-based live attenuated bacterial vectors","volume":"35","author":"Wang","year":"2012","journal-title":"J. Immunother. (Hagerstown Md., 1997)"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0185","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.stem.2012.02.016","article-title":"Distinct lineage specification roles for NANOG OCT4, and SOX2 in human embryonic stem cells","volume":"10","author":"Wang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0190","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0195","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.biomaterials.2012.03.061","article-title":"Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0200","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature07314","article-title":"In vivo reprogramming of adult pancreatic exocrine cells to beta-cells","volume":"455","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2016.09.081_bib0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","article-title":"Generation of induced pluripotent stem cells using recombinant proteins","volume":"4","author":"Zhou","year":"2009","journal-title":"Cell Stem Cell"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316309279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316309279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:39:03Z","timestamp":1759916343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316309279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0378517316309279"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.081","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted release of transcription factors for cell reprogramming by a natural micro-syringe","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.09.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}